Literature DB >> 24127041

Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.

Peng Xia1, Tianbo Jin, Tingting Geng, Ting Sun, Xiaolan Li, Chengxue Dang, Longli Kang, Chao Chen, Jiying Sun.   

Abstract

Breast cancer is a heterogeneous disease which is influenced by genetic, environmental, and lifestyle factors. Genetic susceptibility is likely to be due to variants conferring more moderate risks. To identify susceptibility alleles, we conducted a case-control association study in 185 breast cancer cases and 199 controls in the Han population. We genotyped 14 tagging single nucleotide polymorphisms previously implicated in breast cancer using Sequenom MassARRAY SNP genotyping method and identified rs3734805 in the ESR1 gene and rs2048672 in the FLJ43663 gene were associated with breast cancer risk. Allele "C" of rs3734805 was associated with increased breast cancer progression by χ (2) test and additive model analysis (OR = 1.36; 95% CI, 1.01-1.82; p = 0.042). Using recessive model analysis, we found that genotype "GG" of rs2048672 was the protective genotype during breast cancer progression (OR = 0.55; 95% CI, 0.32-0.95; p = 0.029). Our results provide additional insights into the opposing roles of the ESR1 and FLJ43663 genes in breast cancer onset and progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24127041     DOI: 10.1007/s13277-013-1289-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  Statistics notes. The odds ratio.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  2000-05-27

2.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

3.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

4.  Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.

Authors:  Qiuyin Cai; Jirong Long; Wei Lu; Shimian Qu; Wanqing Wen; Daehee Kang; Ji-Young Lee; Kexin Chen; Hongbing Shen; Chen-Yang Shen; Hyuna Sung; Keitaro Matsuo; Christopher A Haiman; Ui Soon Khoo; Zefang Ren; Motoki Iwasaki; Kai Gu; Yong-Bing Xiang; Ji-Yeob Choi; Sue K Park; Lina Zhang; Zhibin Hu; Pei-Ei Wu; Dong-Young Noh; Kazuo Tajima; Brian E Henderson; Kelvin Y K Chan; Fengxi Su; Yoshio Kasuga; Wenjing Wang; Jia-Rong Cheng; Keun-Young Yoo; Jong-Young Lee; Hong Zheng; Yao Liu; Ya-Lan Shieh; Sung-Won Kim; Jong Won Lee; Hiroji Iwata; Loic Le Marchand; Sum Yin Chan; Xiaoming Xie; Shoichiro Tsugane; Min Hyuk Lee; Shenming Wang; Guoliang Li; Shawn Levy; Bo Huang; Jiajun Shi; Ryan Delahanty; Ying Zheng; Chun Li; Yu-Tang Gao; Xiao-Ou Shu; Wei Zheng
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

5.  High-throughput oncogene mutation profiling in human cancer.

Authors:  Roman K Thomas; Alissa C Baker; Ralph M Debiasi; Wendy Winckler; Thomas Laframboise; William M Lin; Meng Wang; Whei Feng; Thomas Zander; Laura MacConaill; Laura E Macconnaill; Jeffrey C Lee; Rick Nicoletti; Charlie Hatton; Mary Goyette; Luc Girard; Kuntal Majmudar; Liuda Ziaugra; Kwok-Kin Wong; Stacey Gabriel; Rameen Beroukhim; Michael Peyton; Jordi Barretina; Amit Dutt; Caroline Emery; Heidi Greulich; Kinjal Shah; Hidefumi Sasaki; Adi Gazdar; John Minna; Scott A Armstrong; Ingo K Mellinghoff; F Stephen Hodi; Glenn Dranoff; Paul S Mischel; Tim F Cloughesy; Stan F Nelson; Linda M Liau; Kirsten Mertz; Mark A Rubin; Holger Moch; Massimo Loda; William Catalona; Jonathan Fletcher; Sabina Signoretti; Frederic Kaye; Kenneth C Anderson; George D Demetri; Reinhard Dummer; Stephan Wagner; Meenhard Herlyn; William R Sellers; Matthew Meyerson; Levi A Garraway
Journal:  Nat Genet       Date:  2007-02-11       Impact factor: 38.330

Review 6.  Tamoxifen versus aromatase inhibitors for breast cancer prevention.

Authors:  Wei Yue; Ji-Ping Wang; Yuebai Li; Wayne P Bocchinfuso; Kenneth S Korach; Prabu D Devanesan; Eleanor Rogan; Ercole Cavalieri; Richard J Santen
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

7.  Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

Authors:  Wei Zheng; Jirong Long; Yu-Tang Gao; Chun Li; Ying Zheng; Yong-Bin Xiang; Wanqing Wen; Shawn Levy; Sandra L Deming; Jonathan L Haines; Kai Gu; Alecia Malin Fair; Qiuyin Cai; Wei Lu; Xiao-Ou Shu
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

8.  Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

Authors:  Olivia Fletcher; Nichola Johnson; Nick Orr; Fay J Hosking; Lorna J Gibson; Kate Walker; Diana Zelenika; Ivo Gut; Simon Heath; Claire Palles; Ben Coupland; Peter Broderick; Minouk Schoemaker; Michael Jones; Jill Williamson; Sarah Chilcott-Burns; Katarzyna Tomczyk; Gemma Simpson; Kevin B Jacobs; Stephen J Chanock; David J Hunter; Ian P Tomlinson; Anthony Swerdlow; Alan Ashworth; Gillian Ross; Isabel dos Santos Silva; Mark Lathrop; Richard S Houlston; Julian Peto
Journal:  J Natl Cancer Inst       Date:  2011-01-24       Impact factor: 13.506

9.  Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.

Authors:  Badan Sehrawat; Malinee Sridharan; Sunita Ghosh; Paula Robson; Carol E Cass; John R Mackey; Russell Greiner; Sambasivarao Damaraju
Journal:  Hum Genet       Date:  2011-03-19       Impact factor: 4.132

10.  Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.

Authors:  Mia M Gaudet; Roger L Milne; Angela Cox; Nicola J Camp; Ellen L Goode; Manjeet K Humphreys; Alison M Dunning; Jonathan Morrison; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Fergus J Couch; Janet E Olson; Xianshu Wang; Jenny Chang-Claude; Dieter Flesch-Janys; Sascha Abbas; Ramona Salazar; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Annika Lindblom; Sara Margolin; Tuomas Heikkinen; Kati Kämpjärvi; Kirsimari Aaltonen; Heli Nevanlinna; Natalia Bogdanova; Irina Coinac; Peter Schürmann; Thilo Dörk; Claus R Bartram; Rita K Schmutzler; Sandrine Tchatchou; Barbara Burwinkel; Hiltrud Brauch; Diana Torres; Ute Hamann; Christina Justenhoven; Gloria Ribas; José I Arias; Javier Benitez; Stig E Bojesen; Børge G Nordestgaard; Henrik L Flyger; Julian Peto; Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Peter A Fasching; Matthias W Beckmann; Reiner Strick; Arif B Ekici; Annegien Broeks; Marjanka K Schmidt; Flora E van Leeuwen; Laura J Van't Veer; Melissa C Southey; John L Hopper; Carmel Apicella; Christopher A Haiman; Brian E Henderson; Loic Le Marchand; Laurence N Kolonel; Vessela Kristensen; Grethe Grenaker Alnaes; David J Hunter; Peter Kraft; David G Cox; Susan E Hankinson; Caroline Seynaeve; Maaike P G Vreeswijk; Rob A E M Tollenaar; Peter Devilee; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Kamila Czene; Per Hall; Yuqing Li; Jianjun Liu; Sabapathy Balasubramanian; Saeed Rafii; Malcolm W R Reed; Karen A Pooley; Don Conroy; Caroline Baynes; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Chen-Yang Shen; Hui-Chun Wang; Jyh-Cherng Yu; Pei-Ei Wu; Hoda Anton-Culver; Argyrios Ziogoas; Kathleen Egan; Polly Newcomb; Linda Titus-Ernstoff; Amy Trentham Dietz; Alice J Sigurdson; Bruce H Alexander; Parveen Bhatti; Kristina Allen-Brady; Lisa A Cannon-Albright; Jathine Wong; Georgia Chenevix-Trench; Amanda B Spurdle; Jonathan Beesley; Paul D P Pharoah; Doug F Easton; Montserrat Garcia-Closas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

View more
  7 in total

1.  The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.

Authors:  Nataliya Babyshkina; Sergey Vtorushin; Marina Zavyalova; Stanislav Patalyak; Tatyana Dronova; Nikolay Litviakov; Elena Slonimskaya; Julia Kzhyshkowska; Nadejda Cherdyntseva; Evgeny Choynzonov
Journal:  Clin Exp Med       Date:  2016-05-25       Impact factor: 3.984

2.  Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption.

Authors:  Irma Karabegović; Eliana Portilla-Fernandez; Yang Li; Jiantao Ma; Silvana C E Maas; Daokun Sun; Emily A Hu; Brigitte Kühnel; Yan Zhang; Srikant Ambatipudi; Giovanni Fiorito; Jian Huang; Juan E Castillo-Fernandez; Kerri L Wiggins; Niek de Klein; Sara Grioni; Brenton R Swenson; Silvia Polidoro; Jorien L Treur; Cyrille Cuenin; Pei-Chien Tsai; Ricardo Costeira; Veronique Chajes; Kim Braun; Niek Verweij; Anja Kretschmer; Lude Franke; Joyce B J van Meurs; André G Uitterlinden; Robert J de Knegt; M Arfan Ikram; Abbas Dehghan; Annette Peters; Ben Schöttker; Sina A Gharib; Nona Sotoodehnia; Jordana T Bell; Paul Elliott; Paolo Vineis; Caroline Relton; Zdenko Herceg; Hermann Brenner; Melanie Waldenberger; Casey M Rebholz; Trudy Voortman; Qiuwei Pan; Myriam Fornage; Daniel Levy; Manfred Kayser; Mohsen Ghanbari
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

3.  MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population.

Authors:  Kai Wang; Yi Zhou; Gang Li; Xinli Wen; Yuan Kou; Jiao Yu; Haifeng He; Qian Zhao; Feng Xue; Jin Wang; Xinhan Zhao
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

4.  The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer.

Authors:  Juan Wang; Yonggang Shi; Gaochao Wang; Shiliang Dong; Daoke Yang; Xiaoxiao Zuo
Journal:  Mol Genet Genomic Med       Date:  2019-07-11       Impact factor: 2.183

5.  Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population.

Authors:  Huangfu Wu; Guisheng He; Tao Song; Yazhen Zhang; Xiuxiu Chen; Huamin Chen; Wei Xiong; Chuanwei Sun; Chaoyang Zhao; Yunjing Chen
Journal:  Mol Genet Genomic Med       Date:  2019-07-08       Impact factor: 2.183

6.  Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.

Authors:  Lei Chen; Tao Zeng; Xiaoyong Pan; Yu-Hang Zhang; Tao Huang; Yu-Dong Cai
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

7.  The association of CASC16 variants with breast Cancer risk in a northwest Chinese female population.

Authors:  Xiaoxiao Zuo; Huanhuan Wang; Yin Mi; Yue Zhang; Xiaofei Wang; Ya Yang; Suna Zhai
Journal:  Mol Med       Date:  2020-01-29       Impact factor: 6.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.